Global Infertility Drug Pipeline Analysis
The market for reproductive medicine is experiencing a paradigm shift with new l...
• Administrative Route
• Drug Class
• ATC Codes
Infertility Drug Pipeline by Clinical Phase:
• Research: 1
• Preclinical: ...
Upcoming SlideShare
Loading in …5
×

Global Infertility Drug Pipeline Analysis

86 views

Published on

“Global Infertility Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of infertility. Research report covers all the ongoing drugs being developed in various development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the infertility treatment drug market based upon development process.

For Report Sample Contact: rajesh@pnspharma.com

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Global Infertility Drug Pipeline Analysis

  1. 1. Global Infertility Drug Pipeline Analysis The market for reproductive medicine is experiencing a paradigm shift with new latest techniques being used and awareness among people increasing due to imparting knowledge about these techniques. The infertility drugs market promises significant room for growth. The market has high potential to scale up in order to meet the needs of infertile couples and also due to growth in reproductive tourism. Venture capitalists have entered the market by investing huge amounts in setting up chains of infertility clinics, which provide drugs and treatment. The most lucrative markets for infertility drugs are the emerging nations such as India, Brazil, China and Mexico, where the population is huge and there exist large pool of people being affected by lifestyle diseases, thus leading to infertility. “Global Infertility Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of infertility. Research report covers all the ongoing drugs being developed in various development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the infertility treatment drug market based upon development process. For Report Sample Contact: rajesh@pnspharma.com Following parameters for each drug profile in development phase are covered in “Global Infertility Drug Pipeline Analysis” research report: • Drug Profile Overview • Alternate Names for Drug • Active Indication • Phase of Development • Mechanism of Action • Brand Name • Patent Information • Orphan Designation by Indication, Country & Organisation • Country for Clinical Trial • Owner / Originator/ Licensee/Collaborator
  2. 2. • Administrative Route • Drug Class • ATC Codes Infertility Drug Pipeline by Clinical Phase: • Research: 1 • Preclinical: 12 • Phase-I: 2 • Phase-II: 7 • Phase-III: 8 • Preregistration: 1 • Marketed: 19 For Report Sample Contact: rajesh@pnspharma.com Each Drug Profile has Tables Representing Following Information: • Alternate Names • Originator & Owner • Collaborator • Technology Provider • Licensee • Highest Development Phase • Indications • Class • Mechanism of Action • ATC code • Designated Brand Name & Orphan Designation

×